BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4114753)

  • 21. Use of chemotherapy as an adjuvant to surgery for bronchogenic carcinoma.
    Higgins GA
    Cancer; 1972 Nov; 30(5):1383-7. PubMed ID: 4343295
    [No Abstract]   [Full Text] [Related]  

  • 22. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bronchial arteriography and intraarterial chemotherapy in bronchogenic carcinoma (author's transl)].
    Hellekant C
    Radiologe; 1979 Dec; 19(12):521-7. PubMed ID: 229511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selective bronchial arteriography and infusion chemotherapy in patients with bronchogenic carcinoma].
    Wu YM
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Apr; 11(2):74-6, 126-7. PubMed ID: 3143488
    [No Abstract]   [Full Text] [Related]  

  • 26. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
    Host H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
    [No Abstract]   [Full Text] [Related]  

  • 28. Bronchial arterial perfusion with cytotoxic agents for bronchogenic carcinoma. Preliminary report.
    Tate CF; Viamonte M; Agnew JR
    Am Rev Respir Dis; 1968 Apr; 97(4):685-93. PubMed ID: 4296229
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of lung cancer by a cooperative group: EORTC Lung Cancer Working Party (Belgium)].
    Klastersky J; Sculier JP
    Rev Med Brux; 1983 Sep; 4(7):485-9. PubMed ID: 6316462
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemotherapy of bronchogenic cancer (author's transl)].
    Schmidt CG
    Langenbecks Arch Chir; 1981; 355():123-5. PubMed ID: 6279988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
    Brunner KW; Marthaler T; Müller W
    Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
    [No Abstract]   [Full Text] [Related]  

  • 32. Small cell bronchogenic carcinoma. A prolonged remission following chemotherapy.
    Cohen MH
    JAMA; 1977 Jun; 237(23):2528. PubMed ID: 576972
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapeutic drugs marked with radioactive isotopes.
    Monod O; Rymer M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):245-9. PubMed ID: 4125742
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of small cell bronchogenic carcinoma with VM-26.
    Woods RL; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):2011-3. PubMed ID: 230897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hexamethylmelamine in inoperable bronchogenic carcinoma.
    Takita H
    N Y State J Med; 1972 Feb; 72(4):477-80. PubMed ID: 4334448
    [No Abstract]   [Full Text] [Related]  

  • 36. [Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide].
    Kochnowski G; Rozek G; Wisńiewski J
    Wiad Lek; 1976 Feb; 29(4):270-1. PubMed ID: 1251645
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of inoperable bronchogenic carcinoma.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1985; 27(3):175-89. PubMed ID: 3017850
    [No Abstract]   [Full Text] [Related]  

  • 40. Lung cancer treatment with high cyclophosphamide doses versus high cyclophosphamide doses plus radiotherapy.
    Araujo CE; Barrague J; Tagle J; Tessler J
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1449-53. PubMed ID: 231593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.